Howland Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Buy |
31,795
+5,107
| +19% | +$2.68M | 0.68% | 45 |
|
|
2025
Q1 | $16.9M | Buy |
26,688
+11,251
| +73% | +$7.14M | 0.75% | 44 |
|
|
2024
Q4 | $11M | Buy |
15,437
+14,179
| +1,127% | +$10.1M | 0.48% | 51 |
|
|
2024
Q3 | $1.32M | Sell |
1,258
-57
| -4% | -$59.9K | 0.06% | 135 |
|
|
2024
Q2 | $1.38M | Sell |
1,315
-18
| -1% | -$18.9K | 0.07% | 121 |
|
|
2024
Q1 | $1.28M | Hold |
1,333
| – | – | 0.06% | 124 |
|
|
2023
Q4 | $1.17M | Sell |
1,333
-8
| -0.6% | -$7.03K | 0.06% | 128 |
|
|
2023
Q3 | $1.1M | Sell |
1,341
-8
| -0.6% | -$6.58K | 0.06% | 124 |
|
|
2023
Q2 | $969K | Sell |
1,349
-4
| -0.3% | -$2.87K | 0.06% | 131 |
|
|
2023
Q1 | $1.11M | Sell |
1,353
-83
| -6% | -$68.2K | 0.07% | 118 |
|
|
2022
Q4 | $1.04M | Sell |
1,436
-40
| -3% | -$28.9K | 0.06% | 121 |
|
|
2022
Q3 | $1.02M | Buy |
1,476
+532
| +56% | +$367K | 0.07% | 120 |
|
|
2022
Q2 | $558K | Sell |
944
-15
| -2% | -$8.87K | 0.03% | 156 |
|
|
2022
Q1 | $670K | Buy |
959
+90
| +10% | +$62.9K | 0.04% | 134 |
|
|
2021
Q4 | $549K | Sell |
869
-38
| -4% | -$24K | 0.03% | 147 |
|
|
2021
Q3 | $549K | Hold |
907
| – | – | 0.03% | 158 |
|
|
2021
Q2 | $507K | Sell |
907
-5
| -0.5% | -$2.8K | 0.03% | 167 |
|
|
2021
Q1 | $432K | Buy |
912
+93
| +11% | +$44.1K | 0.02% | 174 |
|
|
2020
Q4 | $396K | Hold |
819
| – | – | 0.02% | 171 |
|
|
2020
Q3 | $458K | Hold |
819
| – | – | 0.03% | 150 |
|
|
2020
Q2 | $511K | Sell |
819
-60
| -7% | -$37.4K | 0.04% | 144 |
|
|
2020
Q1 | $429K | Sell |
879
-88
| -9% | -$42.9K | 0.04% | 144 |
|
|
2019
Q4 | $363K | Buy |
+967
| New | +$363K | 0.03% | 170 |
|